🔗 Share this article

An underground economy for unlicensed slimming drugs is being driven by TikTok fitness influencers and sellers on messaging platforms, according to new investigations.

Investigational Treatment Gaining Traction Online

The experimental drug, which is still in clinical trials, is being advertised by online personalities for its alleged fat-burning properties. Followers are encouraged to message these accounts directly for source information, while also obtaining discount codes.

Thriving Trade on Messaging Platforms

Separately, a flourishing trade exists on messaging services, where groups with thousands of members share “before and after” photos, injection guides and assertions of next-day British shipping. Sellers promote the substance there before directing customers to other platforms for transactions.

Understanding Retatrutide

Retatrutide is an investigational injectable created by American pharmaceutical company Eli Lilly. The drug targets three intestinal hormones – GLP-1, GIP and pancreatic hormone. Early trials indicate it could help individuals lose up to a quarter of their body weight. Referred to as the “triple G”, the substance is being hailed digitally as the successor to Ozempic.

Medical Professionals Voice Worries

However, physicians and chemists have warned that the distribution of what remains an unlicensed medication in the UK is a cause for concern and could result in individuals injecting substances of unknown origin.

Several experts said the popularity for retatrutide could be connected to the increasing price of approved weight loss products such as Mounjaro.

Regulatory Status and Enforcement

Selling retatrutide on TikTok or messaging apps is illegal in the United Kingdom, as it is an unlicensed drug that must not be promoted or distributed for human use under the British medical regulations.

Some content creators try to sidestep the rules by calling to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted drug, but advertising and supply can still violate medicines, marketing, and customer laws, potentially leading to fines, legal action or imprisonment.

Service Reaction and Content Removal

Based on TikTok, the service has taken down violative material and banned associated keywords and query recommendations. The organization stated it was committed to maintaining the platform secure and allocating resources in enhancing compliance measures.

Online Marketplace Operations

Research also discovered groups with up to nine thousand members selling retatrutide using the platform's built-in discovery tool, which operates like a online catalog. Typing “retatrutide” immediately displays groups with thousands of users, populated with photos of weight loss, glowing testimonials and step-by-step instructions for preparing or injecting at home.

Within moments of entering one community, a seller shared contact information, where the majority of purchases take place. The seller sent an guidebook and promised delivery within 48 hours. When asked whether the substance was genuine, one seller responded: “You can’t be sure.” Another provided a image of a alleged testing documentation. None inquired about weight, medical conditions or previous experience.

Item Information and Pricing

Within these communities, messages show black plastic packages with postal service labels, claiming to include new batches. One communication read: “It took eight of us to load them this morning.”

Buyers can choose between powder vials, prepared at residence with purified liquid, or ready-to-use pens usually priced at £160 for 20 milligrams. When questioned how long a pen should last, vendors give conflicting responses varying between a few weeks to “depends on your body”.

Platform Moderation and Safety Actions

A spokesperson for the messaging service stated it regularly moderated harmful material on its platform including material that encouraged the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.

Healthcare Professional Warnings

“People are injecting substances they cannot confirm. Although the science behind retatrutide is sound, these digital products may not include what they claim,” said Jason Murphy, the director of pharmacy at Chemist4U.

A medical professional of Asda Online Doctor connected the surge in demand to current cost increases for approved weight-loss medications such as Mounjaro. “With prices increasing, patients are turning to social media. But counterfeit treatments are extremely risky. You can’t be certain what’s contained or whether the conditions they were produced in was sterile,” she said.

Her team has previously seen patients harmed by personal administration from unconfirmed sources. “We understand the disappointment, but purchasing from Telegram or WhatsApp is gambling with your health,” stated the doctor. “These substances could be contaminated or improperly measured.”

Producer Position

A representative from Eli Lilly said the substance was in phase 3 research studies and had not been reviewed or authorized by any government authority anywhere in the world. “Consequently at this point no one can sell [it] for human use,” they said, adding that any product “misleadingly claiming itself as a Lilly investigational substance not yet authorized … may expose users to potentially serious health risks”.